Hinokiflavone 是一种 SUMO protease 抑制剂,可抑制 sentrin 特异性蛋白酶 1 (SENP1) 的活性。Hinokiflavone 具有明显的细胞毒性,能抑制MMP-9的活性。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Hinokiflavone, a natural product isolated and purified from the leaves of Platycladus orientalis, with significant cytotoxicity, can inhibit the activity of MMP-9. |
| Concentration | Treated Time | Description | References | |
| LO2 | 0, 10, 20, 40, 80, 120, 160, 240, 320 µmol/L | 24, 48, 72 hours | HF showed much lower cytotoxicity against LO2 cells, with IC50 values of 159.1 ± 5.6 µmol/L (24 hours), 104.7 ± 4.5 µmol/L (48 hours), and 75.7 ± 2.8 µmol/L (72 hours). | J Cell Mol Med. 2020 Jul;24(14):8151-8165 |
| HepG2 | 0, 10, 20, 30, 40, 60, 80, 100 µmol/L | 24, 48, 72 hours | HF significantly inhibited the proliferation of HepG2 cells, with IC50 values of 80.8 ± 2.6 µmol/L (24 hours), 57.5 ± 5.3 µmol/L (48 hours), and 28.1 ± 2.7 µmol/L (72 hours). HF induced G0/G1 phase cell cycle arrest by up-regulating the p53/p21Cip1 signaling pathway and down-regulating G0/G1 phase-related cell cycle regulatory proteins. | J Cell Mol Med. 2020 Jul;24(14):8151-8165 |
| SMMC-7721 | 0, 10, 20, 30, 40, 60, 80, 100 µmol/L | 24, 48, 72 hours | HF significantly inhibited the proliferation of SMMC-7721 cells, with IC50 values of 74.4 ± 8.1 µmol/L (24 hours), 60.3 ± 2.9 µmol/L (48 hours), and 33.0 ± 2.6 µmol/L (72 hours). HF induced G0/G1 phase cell cycle arrest by up-regulating the p53/p21Cip1 signaling pathway and down-regulating G0/G1 phase-related cell cycle regulatory proteins. | J Cell Mol Med. 2020 Jul;24(14):8151-8165 |
| Human lung adenocarcinoma A549 cells | 20 μg/mL | 24 hours | To measure mitochondrial membrane potential, the mitochondrial membrane potential in the HF hybrid micelles group was significantly decreased compared with that in the free HF group, indicating that HF hybrid micelles could induce mitochondria-mediated apoptosis. | Drug Deliv. 2020 Dec;27(1):565-574 |
| Human lung adenocarcinoma A549 cells | 0.78 μg/mL to 50 μg/mL | 24 hours | To evaluate the cytotoxicity of HF hybrid micelles on A549 cells, the results showed that the IC50 value of HF hybrid micelles (7.81 μg/mL) was lower than that of free HF (19.34 μg/mL), indicating that HF hybrid micelles had higher cytotoxicity. | Drug Deliv. 2020 Dec;27(1):565-574 |
| HeLa cells | 500 μM | 90 minutes | Inhibited splicing of Ad1 and HPV18 E6 pre-mRNAs, preventing formation of the B complex | Elife. 2017 Sep 8;6:e27402 |
| AML-2 cells | 0–25 μM | 24 hours | Hinokiflavone attenuated the ubiquitination levels of MDM2 and p53 in AML-2 cells. | Biomolecules. 2022 Apr 27;12(5):643 |
| Klebsiella pneumoniae clinical isolates | 0.25-0.5 µg/mL | Evaluate the antibacterial activity of Hinokiflavone against Klebsiella pneumoniae, showing the highest antibacterial activity | Pharmaceuticals (Basel). 2021 Aug 1;14(8):756 | |
| HT-29 cells | 1-10 μM | 24 hours | To evaluate the inhibitory effect of Hinokiflavone on LPS-induced inflammatory responses, results showed that Hinokiflavone suppressed the production of IL-8 and downregulated the expression of iNOS and COX-2. | Molecules. 2018 Apr 17;23(4):926 |
| RAW 264.7 cells | 1-10 μM | 24 hours | To evaluate the inhibitory effect of Hinokiflavone on LPS-induced inflammatory responses, results showed that Hinokiflavone suppressed the production of NO, IL-6, TNF-α, and downregulated the expression of iNOS and COX-2. | Molecules. 2018 Apr 17;23(4):926 |
| S. aureus USA300 | 64 μg/mL | Assess the effect of Hinokiflavone on the growth of S. aureus USA300, showing no effect on bacterial growth at 64 mg/mL. | Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0024022 | |
| HEK293T cells | 256 μg/mL | 24 hours | Evaluate the cytotoxicity of Hinokiflavone on HEK293T cells, showing no cytotoxicity at 256 mg/mL. | Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0024022 |
| 3T3-L1 cells | 10 μM | Assessed the effect of HF on apoptosis in differentiated 3T3-L1 cells, showing HF induced apoptosis via mitochondrial pathway | J Biol Chem. 2024 Sep;300(9):107721 | |
| Administration | Dosage | Frequency | Description | References | ||
| BALB/c-nu mice | HCC xenograft model | Intraperitoneal injection | 4 or 8 mg/kg | Every other day for ten times | HF significantly inhibited the growth of HCC xenografts, with the average tumour size reduced to 831.8 mm3 and 523 mm3 in the 4 mg/kg and 8 mg/kg groups, respectively, compared to 1604 mm3 in the control group. HF up-regulated the expression levels of cleaved PARP, cleaved caspase-3, and p-JNK, and apoptosis was confirmed by TUNEL assay. | J Cell Mol Med. 2020 Jul;24(14):8151-8165 |
| BALB/c nude mice | A549 xenograft tumor model | Oral administration | 80 mg/kg | Administered on days 2, 4, 6, 8, 10, and 12, lasting for 12 days | To evaluate the in vivo antitumor effect of HF hybrid micelles, the results showed that the tumor volume and weight in the HF hybrid micelles group were significantly lower than those in the free HF group and the control group, with a tumor inhibition rate of 64.76%, significantly higher than that in the free HF group (45.92%). | Drug Deliv. 2020 Dec;27(1):565-574 |
| C57BL/6J mice | MRSA-induced lethal pneumonia model | Subcutaneous injection | 100 mg/kg/d | Every 12 hours for 96 hours | Evaluate the protective effect of Hinokiflavone against MRSA-induced lethal pneumonia, showing more potent than vancomycin alone when combined with vancomycin. | Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0024022 |
| C57BL/6J mice | High-fat diet-induced obesity model | Intraperitoneal injection | 5 mg/kg, 10 mg/kg, 20 mg/kg | Administered every other day for 6 weeks | HF suppressed obesity by inducing apoptosis in adipose tissue, improving glucose tolerance and insulin sensitivity | J Biol Chem. 2024 Sep;300(9):107721 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.86mL 0.37mL 0.19mL |
9.29mL 1.86mL 0.93mL |
18.57mL 3.71mL 1.86mL |
|
| CAS号 | 19202-36-9 |
| 分子式 | C30H18O10 |
| 分子量 | 538.46 |
| SMILES Code | O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(O)=C(OC4=CC=C(C5=CC(C6=C(O)C=C(O)C=C6O5)=O)C=C4)C(O)=C13 |
| MDL No. | MFCD00017455 |
| 别名 | 日本扁柏黄酮 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 50 mg/mL(92.86 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 无水乙醇: 2 mg/mL(3.71 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1